A comparison of haemoglobin levels and doses in haemodialysis patients treated with subcutaneous or intravenous darbepoetin alfa: a German prospective, randomized, multicentre study-Reference-Cited by-同舟云学术

A comparison of haemoglobin levels and doses in haemodialysis patients treated with subcutaneous or intravenous darbepoetin alfa: a German prospective, randomized, multicentre study

Published:2008-07-16 Issue:12 Volume:23 Page:4002-4008
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Bommer J.,Asmus G.,Wenning M.,Bommer G.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/23/12/4002/5336272/gfn416.pdf

Reference24 articles.

1. Erythropoietin in chronic renal failure

2. Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

3. Death, Hospitalization, and Economic Associations among Incident Hemodialysis Patients with Hematocrit Values of 36 to 39%

4. Subcutaneous Compared with Intravenous Epoetin in Patients Receiving Hemodialysis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-02-13

2. Extended Literature Review of the role of erythropoietin stimulating agents (ESA) use in the management of post renal transplant anaemia;Transplantation Reports;2022-06

3. Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients;Kidney Research and Clinical Practice;2021-12-31

4. Erythropoietin Administration for Anemia Due to Chronic Kidney Disease - Subcutaneous OR Intravenous, What Do We Know So Far?;Cureus;2020-09-10

5. Use of the esa resistance index to guide dosing for anaemia management;Journal of Renal Care;2020-03-27